{"id":"W7131843051","doi":"10.5376/cge.2025.13.0030","title":"Advances in the Efficacy and Safety of Immune Checkpoint Inhibitors in Solid Tumors","year":2025,"lang":"","type":"article","venue":"Cancer Genetics and Epigenetics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Immune system; Immunotherapy; Nivolumab; Immune checkpoint; CHEK1; Cancer immunotherapy; Cancer; Pembrolizumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002159056,0.0003209068,0.0007029076,0.0004639381,0.0001513356,0.0009495512,0.0003410804,0.000407985,0.002173801],"category_scores_gemma":[0.00250525,0.0001168166,0.0005277568,0.000481114,0.0004536302,0.0009587343,0.0004395343,0.001587573,0.0004383775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007412625,"about_ca_system_score_gemma":0.0006949774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004154565,"about_ca_topic_score_gemma":0.0008249697,"domain_scores_codex":[0.9995215,0.00014322,0.00004975443,0.00009733199,0.0001320549,0.00005614131],"domain_scores_gemma":[0.9987022,0.0006391071,0.0002742658,0.0000904266,0.0002331662,0.0000608464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00206451,0.0002851653,0.005714898,0.001635042,0.0002875574,0.0001106678,0.00006961988,0.001981721,0.02238759,0.008737789,0.005954228,0.9507712],"study_design_scores_gemma":[0.001777565,0.01460601,0.06805289,0.002809278,0.00241057,0.003815271,0.0003515226,0.008602914,0.1104023,0.0373794,0.7496573,0.0001348683],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1051176,0.85679,0.009242898,0.01667693,0.001057743,0.00006991388,0.0006214265,0.0001984858,0.01022485],"genre_scores_gemma":[0.6315295,0.3485151,0.006697213,0.005925164,0.002579196,0.00009614092,0.00091183,0.00006910988,0.003676701],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002173801,"threshold_uncertainty_score":0.01141834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01052422037669654,"score_gpt":0.2997550131186771,"score_spread":0.2892307927419806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}